dactinomycin has been researched along with rolipram in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cieslinski, LB; Torphy, TJ; Zhou, HL | 1 |
Barnes, PJ; Giembycz, MA; Meja, K; Seldon, PM | 1 |
Canet, E; Cogé, F; Foissier, L; Lonchampt, M | 1 |
Alkhalaf, M; El-Mowafy, AM | 1 |
4 other study(ies) available for dactinomycin and rolipram
Article | Year |
---|---|
Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Albuterol; Cyclic AMP; Cycloheximide; Dactinomycin; Dinoprostone; Dose-Response Relationship, Drug; Humans; Leukemia, Myeloid; Monocytes; Protein Kinases; Pyrrolidinones; Receptors, Adrenergic, beta; Rolipram; Tumor Cells, Cultured; Up-Regulation | 1992 |
Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Albuterol; Amino Acid Sequence; Atrial Natriuretic Factor; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 4; Cycloheximide; Dactinomycin; Dexamethasone; Dinoprostone; Drug Interactions; Flurbiprofen; Humans; Isoenzymes; Leukocytes, Mononuclear; Lipopolysaccharides; Molecular Sequence Data; Nitroprusside; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrrolidinones; Rolipram; Stimulation, Chemical; Time Factors; Tumor Necrosis Factor-alpha | 1995 |
In vitro down-regulation of antigen-induced IL-5 gene expression and protein production by cAMP-specific phosphodiesterase type 4 inhibitor.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Antigens; Asthma; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cycloheximide; Dactinomycin; Down-Regulation; Gene Expression Regulation; Interleukin-5; Male; Mice; Mice, Inbred BALB C; Nucleic Acid Synthesis Inhibitors; Ovalbumin; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Protein Synthesis Inhibitors; Pyrrolidinones; RNA, Messenger; Rolipram; Spleen | 1996 |
Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Antineoplastic Agents, Phytogenic; Arachidonic Acids; Breast Neoplasms; Cell Division; Cyclic AMP; Cyclic GMP; Dactinomycin; Enzyme Activation; Enzyme Inhibitors; Female; Guanylate Cyclase; Humans; Receptors, Estrogen; Resveratrol; Rolipram; Stilbenes; Tamoxifen; Tumor Cells, Cultured | 2003 |